Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
7 hedge funds and large institutions have $69.6M invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 37 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
84% less funds holding
Funds holding: 43 → 7 (-36)
94% less capital invested
Capital invested by funds: $1.08B → $69.6M (-$1.01B)
97% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 37
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$1.15M |
| 2 |
LTI
Laffer Tengler Investments
Nashville,
Tennessee
|
+$664K |
| 3 |
CWM
Calamos Wealth Management
Naperville,
Illinois
|
+$27.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$214M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$167M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$151M |
| 4 |
BlackRock
New York
|
-$106M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$54.3M |
BSX.PRA Hedge Fund Activity: Q4 2020 in Review
7 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q4 2020, worth a combined $69.6M — down 94% from $1.08B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of BSX.PRA and 1 opened new positions — a net loss of 36 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $1.15M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $214M sold.
- 7 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q4 2020, down from 43 in Q3 2020.
- Funds reported $69.6M of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q4 2020, down 94% quarter-over-quarter.
- 1 fund opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q4 2020 and 37 closed out, a net change of -36 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q4 2020 was Russell Investments Group, an estimated $1.15M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q4 2020 was T. Rowe Price Associates, an estimated $214M sold.
Based on aggregated 13F filings for Q4 2020.